Westwind Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-34,529
Closed -$11.5M 45
2024
Q3
$11.5M Sell
34,529
-346,400
-91% -$132M 2.8% 18
2024
Q2
$17.5M Buy
380,929
+338,610
+800% +$134M 4.34% 11
2024
Q1
$17.1M Sell
42,319
-18,107
-30% -$6.37M 4.33% 13
2023
Q4
$18.5M Sell
60,426
-108
-0.2% -$29.2K 5.05% 13
2023
Q3
$14.7M Buy
60,534
+369
+0.6% +$94.4K 4.51% 14
2023
Q2
$14.4M Buy
60,165
+31,273
+108% +$6.5M 4.05% 14
2023
Q1
$5.43M Buy
+28,892
New +$5.98M 1.74% 19

Other funds holding MEDP

Westwind Capital's MEDP Position: Q4 2024 in Review

Westwind Capital sold out of Medpace (MEDP) in Q4 2024, closing a stake of 34,529 shares — an estimated $11.5M sold.

Westwind Capital first reported a position in MEDP in Q1 2023 and held it in 7 quarters. The position peaked at $18.5M in Q4 2023. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Westwind Capital reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Westwind Capital sold 34,529 Medpace shares in Q4 2024, an estimated $11.5M.
  • Westwind Capital first reported a position in Medpace in Q1 2023 and held it in 7 quarters.
  • Westwind Capital's Medpace position peaked at $18.5M in Q4 2023.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Westwind Capital's 13F filing for Q4 2024, filed 7 Jan 2025.